Stay updated on Nivolumab & Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Ipilimumab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T01:32:00.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.1 to v3.7.2 on the error page.
    Difference
    0.2%
    Check dated 2026-10-18T01:12:28.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision number was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T01:46:57.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a minimal header, replacing the prior study details with an error notice.
    Difference
    18%
    Check dated 2026-09-20T00:37:22.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing Revision: v3.6.5, indicating a small platform update to the study details page.
    Difference
    0.1%
    Check dated 2026-08-29T19:53:52.000Z thumbnail image
  6. Check
    81 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.6.5' has been added. The 'Investigator Inquiry Form' and the previous 'Revision: v3.6.4' entry have been removed, reflecting administrative updates to the study record rather than changes to trial content.
    Difference
    0.1%
    Check dated 2026-08-08T17:27:50.000Z thumbnail image

Stay in the know with updates to Nivolumab & Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Ipilimumab in Melanoma Clinical Trial page.